ChemoCentryx Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,060.00
-
-
11,935.00
82,497.00
42,875
Cost of Goods Sold (COGS) incl. D&A
-
543.00
477.00
-
-
-
Gross Income
-
543.00
477.00
-
-
-
SG&A Expense
44,599.00
46,856.00
47,212.00
52,307.00
65,586.00
82,633
EBIT
39,115.00
47,399.00
47,689.00
40,720.00
16,493.00
40,270
Interest Expense
59.00
24.00
-
-
4.00
1,224
Pretax Income
38,673.00
46,929.00
47,305.00
39,963.00
17,859.00
37,966
Consolidated Net Income
38,673.00
46,929.00
47,305.00
39,963.00
17,859.00
37,966
Net Income
38,673.00
46,929.00
47,305.00
39,963.00
17,859.00
37,966
Net Income After Extraordinaries
38,673.00
46,929.00
47,305.00
39,963.00
17,859.00
37,966
Net Income Available to Common
38,673.00
46,929.00
47,305.00
39,963.00
17,859.00
37,966
EPS (Basic)
0.95
1.08
1.08
0.86
0.36
0.76
Basic Shares Outstanding
40,916.00
43,275.00
43,890.00
46,432.00
48,413.00
49,814
EPS (Diluted)
0.95
1.08
1.08
0.86
0.36
0.76
Diluted Shares Outstanding
40,916.00
43,275.00
43,890.00
46,432.00
49,615.00
49,814
EBITDA
38,539.00
46,856.00
47,212.00
40,372.00
16,911.00
39,758
Non-Operating Interest Income
501.00
494.00
384.00
757.00
1,370.00
3,528
About ChemoCentryx
View Profile
